신경외과용 의료기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Neurosurgery Devices Market size is expected to reach USD 52.65 Billion in 2034 from USD 19.36 Billion (2025) growing at a CAGR of 11.76% during 2026-2034.

The global neurosurgery devices market is experiencing robust growth due to the increasing prevalence of neurological disorders and brain-related conditions. Devices used in neurosurgery, such as surgical instruments, navigation systems, and implants, are essential for treating conditions like brain tumors, spinal disorders, and traumatic injuries. Advancements in medical technology have significantly improved surgical precision and patient outcomes.

Key drivers include the growing aging population, which is more susceptible to neurological disorders, and the increasing adoption of minimally invasive surgical techniques. Technological innovations such as robotic-assisted surgeries and advanced imaging systems have further enhanced the effectiveness of neurosurgical procedures. Additionally, rising healthcare expenditure has supported the adoption of advanced medical devices.

In the future, the market is expected to expand with continuous innovation and the development of next-generation surgical technologies. Emerging economies will offer growth opportunities due to improving healthcare infrastructure. As research in neuroscience advances, new treatment approaches and devices will further drive market growth and improve patient care outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Neurostimulation Devices
• Neurointerventional Devices
• Neurosurgical Navigation Systems
• Cerebral Spinal Fluid (CSF) Management Devices
• Others

By Application

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Neuroendoscopy

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Medtronic plc, Johnson Johnson, Stryker Corporation, Abbott Laboratories, B Braun Melsungen AG, Ackermann Instrumente GmbH, Integra LifeSciences Corporation, Boston Scientific Corporation, BIOTRONIK SE Co KG, Adeor Medical AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSURGERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Neurostimulation Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Neurointerventional Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Neurosurgical Navigation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cerebral Spinal Fluid (CSF) Management Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSURGERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Spinal Cord Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Deep Brain Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neuroendoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSURGERY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEUROSURGERY DEVICES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEUROSURGERY DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic Plc
  • 9.2.2 Johnson & Johnson
  • 9.2.3 Stryker Corporation
  • 9.2.4 Abbott Laboratories
  • 9.2.5 B. Braun Melsungen AG
  • 9.2.6 Ackermann Instrumente GmbH
  • 9.2.7 Integra LifeSciences Corporation
  • 9.2.8 Boston Scientific Corporation
  • 9.2.9 BIOTRONIK SE & Co. KG
  • 9.2.10 Adeor Medical AG